Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06334887
Other study ID # PID2021-124409OB-I00_O3
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 26, 2024
Est. completion date May 31, 2024

Study information

Verified date March 2024
Source University of Valencia
Contact Gemma García-Soriano
Phone +34 963983389
Email gemma.garcia@uv.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study is to assess the efficacy of a mobile application called esTOCma in promoting mental health literacy, reducing stigmatizing attitudes related to the Obsessive-Compulsive Disorder (OCD) and improving teachers' confidence in dealing with students that might have OCD. A parallel, randomized controlled trial with two conditions (experimental and control group) will be carried out in a sample of teachers that work in primary and secondary education. Pre-post changes will be assessed. Experimental group will use the app until they finish it (within a set period of 10 days), whereas control group will do nothing for 10 days. Primarily, it is expected that after the use of the app, participants will show an improvement in OCD-related literacy, stigmatizing attitudes, desired social distance and their comfort, confidence and perceived ability in teaching and handling students with OCD. Secondarily, the investigators hypothesize that experimental group might show a reduction in obsessive-compulsive symptoms.


Description:

Adolescence is a critical stage that is associated with a high vulnerability to developing obsessive-compulsive disorder (OCD). Schools are part of the natural developmental context of adolescents, and teachers are involved in their education and personal development. In this sense, teachers play an essential role in the early detection and referral of students with possible obsessional symptoms and will also have to deal with the management of this symptomatology in the classroom. Moreover, teachers often have low knowledge of mental health problems and lack strategies for handling mental symptomatology in the classroom. esTOCma is a mobile health (mHealth) application that has been developed to promote mental health literacy and reduce stigmatizing attitudes associated with OCD. Previous studies have shown that it is a tool with great potential in terms of intervention on stigma and OCD literacy in the general population. Thus, it could be of great interest to use this app in the field of education, and especially in non-university education (primary and secondary education) since adolescents, a highly vulnerable collective to the development of OCD, spend much of their time in the classroom, and often seek help from school staff.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Being a practising teacher in Primary or Secondary education. - Working in the education field as a guidance counsellor, language teacher or therapeutic pedagogue. Exclusion Criteria: - Working in a field other than those mentioned above. - Having less than 18 years old.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Use of esTOCma
Participants of the experimental group will use the esTOCma mobile app until completion, within a set period of 10 days. EsTOCma is a a serious game with 10 missions where users have to free 10 characters who have been imprisoned by a monster called esTOCma, which metaphorically represents the stigma in OCD. With each mission, users will gain knowledge about OCD and free an imprisoned character until the tenth mission, when they will defeat the monster. This game has three modules: (1) Psychoeducation (missions 1-5), where general information about OCD, OCD treatments and where to seek help is provided; (2) Indirect Contact (missions 6 and 7), which consists of a series of audio-visual recordings in which OCD patients report their symptoms and the impact the disorder has had on their lives; and finally, (3) Cognitive Restructuring (missions 8-10), where common dysfunctional beliefs about OCD and OCD treatment are challenged.

Locations

Country Name City State
Spain University of Valencia/ Universitat de València Valencia

Sponsors (2)

Lead Sponsor Collaborator
University of Valencia Ministry of Science and Innovation

Country where clinical trial is conducted

Spain, 

References & Publications (2)

Chaves A, Arnaez S, Castilla D, Roncero M, Garcia-Soriano G. Enhancing mental health literacy in obsessive-compulsive disorder and reducing stigma via smartphone: A randomized controlled trial protocol. Internet Interv. 2022 Jul 13;29:100560. doi: 10.1016/j.invent.2022.100560. eCollection 2022 Sep. — View Citation

Garcia-Soriano G, Arnaez S, Chaves A, Del Valle G, Roncero M, Moritz S. Can an app increase health literacy and reduce the stigma associated with obsessive-compulsive disorder? A crossover randomized controlled trial. J Affect Disord. 2024 Apr 1;350:636-647. doi: 10.1016/j.jad.2024.01.168. Epub 2024 Jan 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in general OCD literacy Score change in the knowledge and the attitudes towards obsessive-compulsive disorder measured by the OCD Knowledge Stigma Assessment Scale (OKSAS). It is a self-report ad hoc questionnaire with 24 items and a response scale ranging from 1 "Completely disagree" to 5 "Completely agree". The total score is the sum of the items and higher score indicate more knowledge about the disorder. Through app completion (an estimation of 10 days).
Primary Change in OCD literacy associated with a vignette Score change in mental health literacy associated with a vignette assesses by:
An ad hoc questionnaire with 2 items: an open-ended question that inquires about what the participants thinks is happening to the person described in the vignette; and a Likert question "To what extent do you feel capable of helping a student like N?" with a 5-point scale (from 1 "Slightly/Not at all confident" to 5 "Extremely/Very confident". Each item will the reviewed individually.
Questionnaire developed by Whitley & Gooderham (2016) composed by 6 items. The 3 items corresponding to Teacher Efficacy, Teacher Expectations and Problem Severity will be used. 4-point Likert scale ranging from 1"Least/Lowest" to 4 "Most/Highest". The total score and each item will be taken into account.
There will be two vignettes that will be randomly assigned. Both portray a student with OCD but one focuses on the contamination content, and the other on the aggressive content.
Through app completion (an estimation of 10 days).
Primary Change in stigmatizing attitudes related to OCD associated with a vignette Score change in stigma associated with a vignette measured by:
Attribution Questionnaire (AQ-9; González-Sanguino, et al., 2019) is a self-report measure. It has a Likert scale ranging from 1 = "Not at all" to 9 = "Very much". Investigators will not use the items corresponding to Coercion, Pity and Avoidance. The higher the score (total and per item), the higher the stigma.
OCD Stigma Measure (OSM; Ponzini et al., 2023) is a self-report measure composed by 16 items and two subscales (Severe Mental Illness-related Stereotypes and Anxiety-relevant Stereotypes). 11 items will be used in this study. A total score (sum of all the items) is interpreted, as well as each subscale.
Through app completion (an estimation of 10 days).
Primary Change in comfort in addressing OCD Score change in the comfort in dealing with people with OCD will be measured by Comfort Questionnaire (Kutcher et al., 2016). It is a self-report instrument with two parts. Part A assesses the sense of comfort in talking to, identifying and advising students with OCD, and part B appraises the referrals, that is, whether participants have identified and advised a student or acquaintance who might have OCD, or if they have sought help for themselves. Part A has a Likert scale ranging from 1 "Completely disagree" to 5 "Completely agree" so the total score will be obtained by adding up and averaging these items. And in part B they have to answer Yes or No, therefore each item will be reviewed individually in terms of percentages. Through app completion (an estimation of 10 days).
Primary Change in desired social distance Score change in desired social distance will be measured by Reported and Intended Behaviour Scale (RIBS; Evans-Lacko et al., 2011). It is a self-report measure with 8 items and it inquires about Reported and Intended Behaviour among four different contexts: (1) living with, (2) working with, (3) living nearby and (4) continuing a relationship with someone with a mental health problem. Investigators will use the 4 items corresponding to Intended Behaviour subscale. Likert scale from 1 "Agree strongly" to 5 " Disagree strongly" and an additional "Don't know" response option. The total score is calculated by adding together the response values, and "Don't know" is coded as a neutral value (i.e. 3).
This questionnaire will be used in association with a vignette.
Through app completion (an estimation of 10 days).
Secondary Change in obsessive-compulsive symptoms Score change in OCD symptoms will be measured by Obsessive-Compulsive Inventory - Revised. The reduced 4-item version (OCI-4; Abramovich et al., 2021) that assesses four dimensions of OCD (washing, checking, ordering, obsessing) will be used. It has a 5-point Likert scale ranging from 0 "Not at all" to 4 "Very much". The items will be added. Through app completion (an estimation of 10 days).
See also
  Status Clinical Trial Phase
Recruiting NCT04934007 - Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder N/A
Recruiting NCT04071990 - Family Involvement in CBGT of OCD: a Randomized Controlled Trial N/A
Completed NCT02541968 - Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Recruiting NCT05391503 - Light Therapy for Obsessive-compulsive Disorder (OCD) N/A
Recruiting NCT04539951 - Pragmatic Trial of Obsessive-compulsive Disorder Phase 2
Completed NCT03416504 - Methods for Managing Intrusive Thoughts N/A
Not yet recruiting NCT06029738 - Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD N/A
Recruiting NCT02844049 - European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS N/A
Completed NCT02911324 - Cannabinoid Medication for Adults With OCD Phase 1/Phase 2
Terminated NCT02909660 - What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder N/A
Completed NCT02217995 - Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients N/A
Terminated NCT02234011 - A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder Phase 2
Withdrawn NCT01953042 - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders N/A
Completed NCT02655926 - Deep Brain Stimulation for Severe Obsessive Compulsive Disorder N/A
Completed NCT00742664 - Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project Phase 1/Phase 2
Completed NCT04919785 - Deep Brain Stimulation in Severe Obsessive-compulsive Disorder N/A
Terminated NCT00758966 - Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Phase 2
Completed NCT00523718 - Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder Phase 2
Completed NCT00074815 - Treatment of Obsessive Compulsive Disorder in Children Phase 3

External Links